Symbols

FATE

Fate Therapeutics·NASDAQ

--(--)

FATE Profile

Fate Therapeutics, Inc.

A clinical-stage biopharmaceutical company that developing programmed cellular immunotherapies for the treatment of cancer diseases

Industry

Pharmaceutical

Established Date

04/27/2007

Listing Date

10/01/2013

Exchange

NASDAQ Stock Exchange

Full-time Employees

161

Fiscal Year Ends

12-31

Website

www.fatetherapeutics.com

Security Type

Common stock

Office address

12278 Scripps Summit Drive, San Diego, California 92131

Business

Introduction

Fate Therapeutics, Inc., was incorporated in Delaware on April 27, 2007 and is headquartered in San Diego, California. As a clinical-stage biopharmaceutical company, the company focuses on the development of off-the-shelf, multi-engineered, induced pluripotent stem cell (iPSC) -derived cellular immunotherapies for patient treatment.